title: Effects of hyperoxia on nitric oxide synthase expression, nitric oxide activity, and lung injury in rat pups.
abstract: Although hyperoxic exposure is an important contributor to the development of bronchopulmonary dysplasia and nitric oxide (NO) has been implicated in the pulmonary response to oxygen, the role of NO in mediating chronic neonatal lung injury is unclear. Therefore, rat pups were exposed to normoxia or hyperoxia (>95% O2) from d 21 to 29. After the rats were killed, their lungs were removed for analysis of nitric oxide synthase (NOS) expression, NO activity as measured by 3',5'-cyclic guanosine monophosphate (cGMP) assay, and lung pathology. Hyperoxia caused 5-fold and 2-fold increases in inducible (i) NOS and endothelial (e) NOS levels, respectively. NO activity was assessed by measuring cGMP levels after normoxic or hyperoxic exposure in the presence and absence of NOS blockade with either aminoguanidine (AG) or Nomega-nitro-L-arginine (L-NNA). cGMP levels were elevated in hyperoxic versus normoxic rats (287+/-15 versus 106+/-9 pmol/mg protein, respectively, p < 0.001), and this increase in cGMP was attenuated after NOS blockade with either AG or L-NNA. Hyperoxic exposure significantly increased lung/body weight ratios and induced histologic changes of interstitial and alveolar edema; however, these hyperoxia-induced histologic changes were not altered by NOS blockade with AG or L-NNA. We conclude that hyperoxic exposure of rat pups up-regulated both iNOS and eNOS and increased NO activity as measured by cGMP levels derived from both iNOS and eNOS. Blockade of NOS reduced cGMP levels in the hyperoxic rat pups; however, it did not seem to reverse the pathologic consequences of hyperoxic exposure.
authors.affiliation: Department of Pediatrics, University Hospitals of Cleveland, Case Western Reserve University, Ohio 44106, USA.
authors.forename: C F
authors.initials: CF
authors.lastname: Potter
authors.forename: N T
authors.initials: NT
authors.lastname: Kuo
authors.forename: C F
authors.initials: CF
authors.lastname: Farver
authors.forename: J T
authors.initials: JT
authors.lastname: McMahon
authors.forename: C H
authors.initials: CH
authors.lastname: Chang
authors.forename: F H
authors.initials: FH
authors.lastname: Agani
authors.forename: M A
authors.initials: MA
authors.lastname: Haxhiu
authors.forename: R J
authors.initials: RJ
authors.lastname: Martin
mesh_terms: D000818:Animals; D001835:Body Weight / Q000502:physiology; D006152:Cyclic GMP / Q000378:metabolism; D018496:Hyperoxia / Q000378:metabolism*; D008168:Lung / Q000378:metabolism* / Q000473:pathology; D008854:Microscopy, Electron; D009569:Nitric Oxide / Q000378:metabolism*; D019001:Nitric Oxide Synthase / Q000096:biosynthesis*; D052247:Nitric Oxide Synthase Type II; D052250:Nitric Oxide Synthase Type III; D009929:Organ Size / Q000502:physiology; D051381:Rats; D017207:Rats, Sprague-Dawley
chemical_list: D009569:Nitric Oxide; D019001:Nitric Oxide Synthase; D052247:Nitric Oxide Synthase Type II; D052250:Nitric Oxide Synthase Type III; C496318:Nos2 protein, rat; C496316:Nos3 protein, rat; D006152:Cyclic GMP